{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:01:51Z","timestamp":1786118511595,"version":"build-2736575974"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.ftd.0000249947.17676.92","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T05:36:23Z","timestamp":1165988183000},"page":"800-806","source":"Crossref","is-referenced-by-count":25,"title":["Analysis of Thiopurine S-methyltransferase Polymorphism in the Population of Serbia and Montenegro and Mercaptopurine Therapy Tolerance in Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"28","author":[{"given":"Lidija","family":"Dokmanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Urosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Janic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Petrucev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Tosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0009-8981(78)90311-X","article-title":"Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.","volume":"85","author":"Weinshilboum","year":"1978","journal-title":"Clin Chim Acta"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00008571-199510000-00003","article-title":"Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults.","volume":"5","author":"McLeod","year":"1995","journal-title":"Pharmacogenetics"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","article-title":"Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.","volume":"6","author":"Krynetski","year":"1996","journal-title":"Pharmacogenetics"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-3476(05)83063-X","article-title":"Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltranferase-deficient child with acute lymphoblastic leukaemia.","volume":"119","author":"Evans","year":"1991","journal-title":"J Paediatr"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/8.2.367","article-title":"Thiopurine methyltransferase alleles in British and Ghanaian populations.","volume":"8","author":"Ameyaw","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-199912000-00012","article-title":"Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.","volume":"9","author":"McLeod","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjp.0702152","article-title":"Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in European population.","volume":"125","author":"De la Moureyre","year":"1998","journal-title":"Br J Pharmacol"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/hmg\/8.2.371","article-title":"Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.","volume":"8","author":"Hon","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","article-title":"The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.","volume":"9","author":"Collie-Duguid","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00008571-200104000-00012","article-title":"Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.","volume":"11","author":"Kumagai","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00008571-200204000-00003","article-title":"Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations.","volume":"12","author":"Chang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","article-title":"Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.","volume":"14","author":"Schaffeler","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1373\/clinchem.2005.050831","article-title":"Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine\/6-mercaptopurine therapy.","volume":"51","author":"Dervieux","year":"2005","journal-title":"Clin Chem"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.fpc.0000174788.69991.6b","article-title":"Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.","volume":"15","author":"Salavaggione","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1073\/pnas.92.4.949","article-title":"A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.","volume":"92","author":"Krynetski","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-12-20210129","first-page":"694","article-title":"Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.","volume":"58","author":"Tai","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0009-9236(98)90021-2","article-title":"Isolation of a human thiopurine S-methyltransferase (TPMT) cDNA with a single nucleotide transition A719G (TPMT3C) and its association with loss of TPMT protein and catalytic activity in humans.","volume":"46","author":"Loennechen","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14622416.3.1.89","article-title":"The thiopurine S-methyltransferase gene locus-implications for clinical pharmacogenomics.","volume":"3","author":"McLeod","year":"2002","journal-title":"Pharmacogenomics"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/dna.1996.15.17","article-title":"Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.","volume":"15","author":"Szumlanski","year":"1996","journal-title":"DNA Cell Biol"},{"key":"R22-12-20210129","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am J Hum Genet"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/sj.leu.2401977","article-title":"Long-term results of large prospective trials in childhood acute lymphoblastic leukemia.","volume":"14","author":"Schrappe","year":"2000","journal-title":"Leukemia"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/beha.2002.0225","article-title":"Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.","volume":"15","author":"Pui","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"R25-12-20210129","first-page":"439","article-title":"Results and significance of six randomized trials in four consecutive ALL-BFM studies.","volume":"33","author":"Riehm","year":"1990","journal-title":"Haematol Blood Transfus"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1200\/JCO.2003.04.096","article-title":"Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.","volume":"21","author":"Burger","year":"2003","journal-title":"J Clin Oncol"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/08035259850158001","article-title":"Pharmacokinetics, dose adjustments, and 6-mercaptopurine\/metothrexate drug interaction in two patients with thiopurine methyltransferase deficiency.","volume":"87","author":"Andersen","year":"1998","journal-title":"Acta Paediatr"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0140-6736(93)93168-Z","article-title":"Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.","volume":"1341","author":"McLeod","year":"1993","journal-title":"Lancet"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/gut.52.1.140","article-title":"Safe treatment of thiopurine S-metyltransferase deficient Crohns disease patients with azathioprine.","volume":"52","author":"Kaskas","year":"2003","journal-title":"Gut"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","article-title":"Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.","volume":"91","author":"Relling","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.leu.2401723","article-title":"Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.","volume":"14","author":"McLeod","year":"2000","journal-title":"Leukemia"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.leu.2402981","article-title":"A novel TPMT missense mutation associated with TPMT deficiency in a 5-year old boy with ALL.","volume":"17","author":"Schaffeler","year":"2003","journal-title":"Leukemia"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.","volume":"105","author":"Rocha","year":"2005","journal-title":"Blood"},{"key":"R34-12-20210129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2005-08-3379","article-title":"Thiopurine metyltransferase in acute lymphoblastic leukemia.","volume":"107","author":"Relling","year":"2006","journal-title":"Blood"},{"key":"R35-12-20210129","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"R36-12-20210129","first-page":"16","article-title":"Moderni lecba detske leukemie.","volume":"9","author":"Stary","year":"2003","journal-title":"Vox Pediatriae"},{"key":"R37-12-20210129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukaemia-current status and future perspectives.","volume":"2","author":"Pui","year":"2001","journal-title":"Lancet Oncol"},{"key":"R38-12-20210129","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","article-title":"Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.","volume":"126","author":"Yates","year":"1997","journal-title":"Ann Intern Med"},{"key":"R39-12-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00043426-200206000-00002","article-title":"Comprehensive assessment of thiopurine S-methyltransferase (TPMT) alleles in three ethnic populations.","volume":"24","author":"Evans","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R40-12-20210129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00007691-200410000-00013","article-title":"Frequency distribution of thiopurine S-methyltransferase alleles in a Polish population.","volume":"26","author":"Kurzawski","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R41-12-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00007691-200310000-00013","article-title":"Phenotypic and genotypic analysis of thiopurine S-methyltransferase polymorphism in the Bulgarian population.","volume":"25","author":"Indjova","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R42-12-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejca.2004.10.027","article-title":"Thiopurine methyltansferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.","volume":"41","author":"Brouwer","year":"2005","journal-title":"Eur J Cancer"},{"key":"R43-12-20210129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1365-2141.1999.01416.x","article-title":"Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukemia.","volume":"105","author":"McLeod","year":"1999","journal-title":"Br J Haematol"},{"key":"R44-12-20210129","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am J Hum Genet"},{"key":"R45-12-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s002280000246","article-title":"Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects.","volume":"57","author":"Rossi","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R47-12-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00008571-200203000-00003","article-title":"Molecular haplotyping of genomic DNA for multiple single-nucleotide polymorphisms located kilobases apart using long-range polymerase chain reaction and intramolecular ligation.","volume":"12","author":"McDonald","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R48-12-20210129","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2001.19.8.2293","article-title":"Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.","volume":"19","author":"Evans","year":"2001","journal-title":"J Clin Oncol"},{"key":"R49-12-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.leu.2400928","article-title":"Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.","volume":"12","author":"Relling","year":"1998","journal-title":"Leukemia"},{"key":"R50-12-20210129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mpo.1127","article-title":"Genetic predisposition and treatment-related leukemia.","volume":"36","author":"Perentesis","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R51-12-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2141.2003.04499.x","article-title":"Late effects among survivors of leukemia and lymphoma during childhood and adolescence.","volume":"122","author":"Robison","year":"2003","journal-title":"Br J Haematol"},{"key":"R52-12-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0140-6736(98)11079-6","article-title":"High incidence of secondary brain tumors after radiotherapy and antimetabolites.","volume":"354","author":"Relling","year":"1999","journal-title":"Lancet"},{"key":"R53-12-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00043426-200009000-00011","article-title":"Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.","volume":"22","author":"McBride","year":"2000","journal-title":"J Pediatr Haematol Oncol"},{"key":"R54-12-20210129","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.293.12.1485","article-title":"Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.","volume":"293","author":"Stanulla","year":"2005","journal-title":"JAMA"},{"key":"R55-12-20210129","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","article-title":"Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.","volume":"93","author":"Relling","year":"1999","journal-title":"Blood"},{"key":"R56-12-20210129","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","article-title":"Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.","volume":"85","author":"McLeod","year":"1995","journal-title":"Blood"},{"key":"R57-12-20210129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics.","volume":"286","author":"Evans","year":"1999","journal-title":"Science"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ftd.0000249947.17676.92","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:14:42Z","timestamp":1786032882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200612000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000249947.17676.92","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}